The Association of American Cancer Institutes (AACI) has announced the election of Stanton L. Gerson, MD, as Vice-President/President-Elect for a 6-year term, effective in October 2014. Dr. Gerson is the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology, Director of the National Cancer Institute (NCI)-Designated Case Comprehensive Cancer Center, in Cleveland, Founding Director of the National Center for Regenerative Medicine, and Distinguished University Professor at Case Western Reserve University. He is also Director of University Hospitals Seidman Cancer Center in Cleveland and a member of the NCI Board of Scientific Advisors.
The Association also announced that Patrick J. Loehrer, Sr, MD, and Thomas A. Sellers, PhD, MPH, have been elected to AACI’s Board of Directors. Dr. Loehrer is Director of the Indiana University Melvin and Bren Simon Cancer Center, in Indianapolis. Dr. Sellers is Director and Executive Vice President of the Moffitt Cancer Center and Research Institute, in Tampa.
Priorities for Term
In a statement submitted to AACI members, Dr. Gerson said that in his new AACI leadership role, he will prioritize three critical aspects of the nation’s cancer centers program by: (1) encouraging the centers to work more closely together to lower health-care costs and improve outcomes through nationally coordinated research and translation, (2) expanding the use of cancer patient data to further health improvements and research discoveries, and (3) making optimal use of the cancer center director and administrative leader network, including partnering with funding agencies, to set the policy agenda for cancer research, dissemination of discoveries, and cancer health care.
Drs. Gerson, Loehrer, and Seller’s terms will commence on October 27 during the AACI/CCAF Annual Meeting in Chicago. ■
